Utility of B-type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetes: response to Epshteyn et al

Diabetes Care. 2004 Mar;27(3):848; author reply 848-9. doi: 10.2337/diacare.27.3.848.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biomarkers / blood
  • Diabetic Angiopathies / blood
  • Diabetic Angiopathies / diagnosis*
  • Humans
  • Mass Screening / methods
  • Natriuretic Peptide, Brain / blood*
  • Reproducibility of Results
  • Ventricular Dysfunction, Left / blood
  • Ventricular Dysfunction, Left / diagnosis*

Substances

  • Biomarkers
  • Natriuretic Peptide, Brain